Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TRIL

Trillium Therapeutics (TRIL) Stock Price, News & Analysis

Trillium Therapeutics logo

About Trillium Therapeutics Stock (NASDAQ:TRIL)

Advanced Chart

Key Stats

Today's Range
$18.44
$18.44
50-Day Range
$17.50
$18.44
52-Week Range
$5.80
$20.96
Volume
8 shs
Average Volume
1.87 million shs
Market Capitalization
$1.94 billion
P/E Ratio
29.74
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TRIL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trillium Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

TRIL Stock News Headlines

Trillium Therapeutics Stock Price History
Trump Makes Major Crypto Announcement
Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design.
See More Headlines

TRIL Stock Analysis - Frequently Asked Questions

Trillium Therapeutics Inc. (NASDAQ:TRIL) issued its earnings results on Thursday, November, 18th. The biotechnology company reported ($0.18) EPS for the quarter, beating analysts' consensus estimates of ($0.19) by $0.01.

Based on aggregate information from My MarketBeat watchlists, some other companies that Trillium Therapeutics investors own include NVIDIA (NVDA), Golden Dragon (CPMD), FuelCell Energy (FCEL), Gilead Sciences (GILD), TG Therapeutics (TGTX), Inovio Pharmaceuticals (INO) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
11/18/2021
Today
7/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TRIL
Fax
N/A
Employees
33
Year Founded
N/A

Profitability

Trailing P/E Ratio
29.74
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$59.35 million
Pretax Margin
-113,720.92%

Debt

Sales & Book Value

Annual Sales
$150 thousand
Price / Sales
12,907.39
Price / Cash Flow
N/A
Book Value
$2.56 per share
Price / Book
7.20

Miscellaneous

Free Float
95,440,000
Market Cap
$1.94 billion
Optionable
Optionable
Beta
2.08
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:TRIL) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners